|
Global Med Technologies, Inc. - Comparative Business Analysis Snapshot
Business Description
Global Med Technologies, Inc.. The Group's principal activity is to design, develop, market and support information management software products for blood banks, hospitals, centralized transfusion centers and other health care related facilities. It provides blood and laboratory software systems and services and is products are deployed in 20 countries and serve over 1,600 transfusion centers, blood banks and laboratories. Its core products include: SafeTrace(R), SafeTrace Tx(R), and our ElDoradoTM product suite. SafeTrace is used to assist community blood centers, hospitals, plasma centers and outpatient clinics. SafeTrace Tx provides electronic cross-matching capabilities to help insure blood compatibility with patient-recipients and tracks, inventories, bills and documents all activities with blood products. It operates in the United States, Canada, European Union and Africa.
Competitor Analysis
This analysis compares Global Med Technologies, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
